Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint Inhibitor

• Chien-Yu Chou,
• Zhi-Qin Li,
• Hsiao-Chen Huang,
• Chung-Heng Hung,
• Shun-Long Weng,
• Shey-Cherng Tzou

Affiliations

Chien-Yu Chou

Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan, Republic Of China

Zhi-Qin Li

Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan, Republic Of China

Hsiao-Chen Huang

Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan, Republic Of China

Chung-Heng Hung

Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan, Republic Of China

Shun-Long Weng

Department of Medicine, MacKay Medical College, New Taipei City, Taiwan, Republic Of China

Shey-Cherng Tzou

Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsin-Chu, Taiwan, Republic Of China